Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash from Financing Activities came in at -$10246.0 in Q2 2026, down 96.85% year-over-year from -$325185.5 in Q2 2025, and up 31.28% quarter-over-quarter from -$14910.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Financing Activities for 17 consecutive years, with -$10246.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 96.85% year-over-year to -$10246.0 in Q2 2026; TTM through Jun 2026 was -$3073.0, a 20.61% increase from a year earlier, with the FY2025 full-year figure at -$812.0, up 89.25% from the prior year.
- Cash from Financing Activities was -$10246.0 for Q2 2026 at Vycor Medical, up from -$14910.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $68409.0 in Q1 2022 and troughed at -$17690.0 in Q1 2025.
- A 5-year average of $7365.4 and a median of -$9532.5 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 293.33% in 2022 and slumped 130.31% in 2023, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $37497.0 in 2022, then sank by 130.31% to -$11367.0 in 2023, then fell by 22.06% to -$13874.0 in 2024, then retreated by 7.21% to -$14874.0 in 2025, then soared by 31.11% to -$10246.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$10246.0 (Q2 2026), -$14910.0 (Q1 2026), and -$14874.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -10,246.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,246.00 |
| Mar 31, 2026 | -14,910.00 |
| Dec 31, 2025 | -14,874.00 |
| Sep 30, 2025 | 36,957.00 |
| Jun 30, 2025 | -5,205.00 |
| Mar 31, 2025 | -17,690.00 |
| Dec 31, 2024 | -13,874.00 |
| Sep 30, 2024 | 32,898.00 |
| Jun 30, 2024 | -10,595.00 |
| Mar 31, 2024 | -15,983.00 |
| Dec 31, 2023 | -11,367.00 |
| Sep 30, 2023 | 34,536.00 |
| Jun 30, 2023 | -8,819.00 |
| Mar 31, 2023 | -14,139.00 |
| Dec 31, 2022 | 37,497.00 |
| Sep 30, 2022 | 65,600.00 |
| Jun 30, 2022 | -5,617.00 |
| Mar 31, 2022 | 68,409.00 |
| Dec 31, 2021 | -19,395.00 |
| Sep 30, 2021 | 38,727.00 |